Only coding sequences are targeted, and each shRNA should be chosen such that it contains more than three mismatches to any other gene. Known single-nucleotide polymorphisms should be avoided ...
The company’s clinical pipeline is also complemented by a portfolio of preclinical-stage candidates leveraging several technologies including short hairpin RNA (shRNA). Celyad’s unique value ...